GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Innogene Co Ltd (XKRX:344860) » Definitions » Ending Cash Position

Innogene Co (XKRX:344860) Ending Cash Position : ₩1,263 Mil (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Innogene Co Ending Cash Position?

Innogene Co's Ending Cash Position for the quarter that ended in Dec. 2024 was ₩1,263 Mil.

Innogene Co's quarterly Ending Cash Position increased from Jun. 2024 (₩410 Mil) to Sep. 2024 (₩682 Mil) and increased from Sep. 2024 (₩682 Mil) to Dec. 2024 (₩1,263 Mil).

Innogene Co's annual Ending Cash Position declined from Dec. 2022 (₩1,398 Mil) to Dec. 2023 (₩1,307 Mil) and declined from Dec. 2023 (₩1,307 Mil) to Dec. 2024 (₩1,263 Mil).


Innogene Co Ending Cash Position Historical Data

The historical data trend for Innogene Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innogene Co Ending Cash Position Chart

Innogene Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Ending Cash Position
Get a 7-Day Free Trial 716.92 1,313.49 1,398.14 1,306.81 1,262.80

Innogene Co Quarterly Data
Dec18 Dec19 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,306.81 928.31 410.18 681.60 1,262.80

Innogene Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Innogene Co's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=1306.814+-44.013
=1,263

Innogene Co's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=681.6+581.201
=1,263


Innogene Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Innogene Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Innogene Co Business Description

Traded in Other Exchanges
N/A
Address
No. 301, 28, Digital-ro 33-gil, Guro-gu, Seoul, KOR
Innogene Co Ltd is a bio-technology company. The company provides treatment solutions using stem cells and databases for hair loss, psoriasis, skin regeneration and hair follicle formation. Also, the company helps in hair loss diagnosis.

Innogene Co Headlines

No Headlines